Takarazuka, Japan

Misashi Hashimoto

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Misashi Hashimoto. Retrieved from https://idiyas.com/inventor/misashi-hashimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Misashi Hashimoto - Innovator in Antimicrobial Composition

Introduction

Misashi Hashimoto, an accomplished inventor based in Takarazuka, Japan, has made significant contributions to the field of pharmaceuticals through his innovative research. He is known for his expertise in antimicrobial compositions, particularly in the development of cephalosporin analogues.

Latest Patents

Hashimoto holds one patent titled "Cephalosporin Analogues and Antimicrobial Compositions." This invention focuses on cephalosporin analogues and pharmaceutically acceptable salts that exhibit high antimicrobial activity, showcasing his commitment to advancing medicinal chemistry.

Career Highlights

Currently, Misashi Hashimoto works at Fujisawa Pharmaceutical Company, Ltd., where he applies his extensive knowledge in drug development. His work is complemented by a professional background that emphasizes research and innovation in the pharmaceutical industry.

Collaborations

Throughout his career, Hashimoto has collaborated with notable colleagues such as Keiji Hemmi and Matsuhiko Aratari. These partnerships highlight the importance of teamwork in scientific advancements and the development of effective pharmaceutical solutions.

Conclusion

With his innovative contributions to antimicrobial compositions, Misashi Hashimoto exemplifies the role of inventors in the progression of healthcare. His dedication to research continues to impact the pharmaceutical landscape positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…